PRIMEMD INC.

As of December 31, 2008, PRIMEMD INC. carries a market capitalization of 230,462.70, placing it among publicly traded companies globally. Its enterprise value stands at 153,881.70, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2008, PRIMEMD INC. has 3.07M shares outstanding.

These figures are as of December 31, 2008. The price-to-sales ratio is 3.29, and the price-to-book ratio stands at 0.20.

These figures are as of December 31, 2008. The EV/Sales ratio of 2.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 153,881.70 versus a market cap of 230,462.70, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2008, PRIMEMD INC. maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended December 31, 2008, PRIMEMD INC. posted a negative return on equity (ROE) of -6.85, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.92, reflecting losses generated across the asset base. The company generates approximately 69,983.00 in revenue per employee across its workforce of 1.00, a quick read on workforce productivity versus industry peers.

As of the close on September 28, 2026, PRIMEMD INC.'s stock has gained approximately 350.00% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.16.

Over the twelve months ended December 31, 2008, PRIMEMD INC. generated 69,983.00 in revenue and converted that into -81,966.00 in net income, yielding earnings per share of -0.03. EBITDA reached -36,751.00, while operating income came in at -40,274.00.

As of December 31, 2008, PRIMEMD INC. holds 435,496.00 in cash and equivalents against 358,915.00 in total debt, resulting in a net debt position of -45,961.00. Total book value stands at 1.15M, with working capital of 72,303.00 providing operational flexibility.

PRIMEMD INC. produced -13,644.00 in operating cash flow over the twelve months ended December 31, 2008.

These figures cover the twelve months ended December 31, 2008. The operating margin of -57.55 and net profit margin of -117.12 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2008. Free cash flow yield is negative at -5.92: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

As of December 31, 2008, PRIMEMD INC. has an Altman Z-Score of -4.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.